SDX Energy shares plunge on London delisting plan
SDX Energy PLC (AIM:SDX, OTC:SDXEF) shares plunged around 60% in value on Friday as it announced it intends to exit the London Stock Exchange, delisting from AIM to take up private company status. It is a cost-cutting move for the company which previously sold its primary asset, a gas field in Egypt, to retain gas-producing assets in Morocco, and last month secured a $4.5 million refinancing of a convertible loan.
Shield Therapeutics ‘on track for 2024' - analyst
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF)'s proposed $10 million equity agreement with AOP Health International Management “should provide some much-needed breathing room” for the AIM-listed pharma group, said Stifel analysts. “This, along with the business looking to lower its cost base by circa 10%, will help strengthen the balance sheet and support achieving cash flow breakeven by 2025 year-end,” they stated, adding that the company is “on track for 2024”.
AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call Transcript
AIM ImmunoTech Inc. (NYSE:AIM ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants Thomas Equels - CEO Christopher McAleer - Scientific Officer Conference Call Participants Ed Woo - Ascendiant Capital Markets Operator Hello, and welcome to the AIM ImmunoTech Third Quarter 2024 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
Pantheon Resources aims to boost profile with US investors
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) has hired an American investor relations firm as it seeks to woo US investors, ahead of the next wave of progress at the AIM-quoted firm's Alaskan oil and gas assets. It has appointed MZ Group to lead its investor relations efforts in the US.
Inheritance tax raid no death kell for AIM market, says London Stock Exchange exec
The potential removal of inheritance tax relief on AIM-listed shares in the upcoming UK Budget has sparked concerns among investors, with many viewing the change as "painful" and "unnecessary". However, Marcus Stuttard, head of AIM and UK primary markets at the London Stock Exchange, doesn't expect Chancellor Rachel Reeve's impending tax raid to be a death knell for the junior market.
First Day of Dealings on AIM and Completion of Fundraise
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. CASCAIS, PORTUGAL / ACCESSWIRE / October 18, 2024 / Pulsar Helium Inc. (AIM:PLSR)(TSXV:PLSR)(OTCQB:PSRHF) ("Pulsar" or the "Company"), the helium project development company, is pleased to announce that its common shares will commence trading today, 18 October 2024, on the AIM market of the London Stock Exchange plc ("AIM") (the "Admission").
Pulsar Helium to join AIM cashed-up after successful equity raise
Pulsar Helium Inc (TSXV:PLSR, OTC:PSRHF), an explorer focused on acreage in Minnesota, has confirmed the completion of a £3.88 million (C$7 million) equity raise, ahead of joining the AIM market later this week. Including a prior pre-IPO raise of £1.13 million, Pulsar will come to the London market holding around £5 million of cash.
Pulsar Announces a Successful Conditional Fundraising and Publication of an AIM Admission Document
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. CASCAIS, PORTUGAL / ACCESSWIRE / October 15, 2024 / Pulsar Helium Inc. (AIM:PLSR)(TSXV:PLSR)(OTCQB:PSRHF) ("Pulsar" or the "Company"), the helium project development company, is pleased to announce that it has conditionally raised £3.875 million (C$7 million) (before expenses), through a placing of new common shares with new and existing investors (the "Fundraising") and is today publishing an AIM admission document ("Admission Document") in connection with the admission of the enlarged share capital of the Company to trading on the AIM Market of the London Stock Exchange plc ("AIM")("Admission").
Jersey Oil & Gas CEO says GBA deals are ‘testament to asset quality', now eyes opportunities outside UK
Jersey Oil and Gas PLC (AIM:JOG, OTC:JYOGF) chief executive Andrew Benitz, in today's interim results statement, highlighted February's farm-out to Serica Energy as testament to the quality of the GBA asset, a project the AIM-quoted firm nurtured from inception. It added to prior deal with NEO Energy, and, ensured Jersey was fully funded for its remaining 20% interest in the Buchan development project.
Optima Health to list on AIM in September after separation from Marlowe
Occupational health specialist Optima Health PLC will begin life as a stand-alone company on the AIM section of the London Stock Exchange later this month after being spun out of Marlow PLC. The Glasgow-based firm said it has no intention to raise new capital in connection with admission.
Pulsar Helium Announces Closing of £1.125 Million Cornerstone Investment and Appointment of CFO to the Board in Preparation for Listing on London's AIM Exchange
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. This announcement is an advertisement and not an admission document or a prospectus and does not constitute or form part of an offer to sell or issue or a solicitation of an offer to subscribe for or buy any securities nor should it be relied upon in connection with any contract or commitment whatsoever in any jurisdiction.
AIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call Transcript
AIM ImmunoTech Inc. (NYSE:AIM ) Q2 2024 Earnings Conference Call August 16, 2024 8:30 AM ET Company Participants Thomas Equels - Chief Executive Officer, President & Executive Vice Chairman Christopher McAleer - Scientific Officer Conference Call Participants Operator Hello, and welcome to the AIM ImmunoTech Second Quarter 2024 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
